![Jonathan Goodman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Goodman
Fondateur chez
KNIGHT THERAPEUTICS INC.
Fortune : 6 M $ au 31/05/2026
Profil
Jonathan Ross Goodman was the founder of Paladin Labs, Inc., founded in 1983, where the titles held included Chairman, President & Chief Executive Officer from 1983 to 2014.
Mr. Goodman is the founder of Knight Therapeutics, Inc., founded in 2013, holding the title of Executive Chairman since 2021.
Current jobs include Director at Medison Biotech 1995 Ltd., Director at POINT Biopharma Corp., Director at POINT Biopharma, Inc. since 2020, Member of the New York State Bar Association, Member of the Massachusetts Bar Association, and Advisor at Maverix Private Equity.
Former jobs include Chairman at Isotechnika, Inc., Chairman at Isotechnika Pharma, Inc. from 2009 to 2010, Honorary Chairman at The Ride To Conquer Cancer, Director at Labopharm, Inc., Director at Medicago, Inc. from 2006 to 2011, Director at Kyowa Kirin International Plc, Director at NeurAxon, Inc., Director at Medimetriks Pharmaceuticals, Inc., Director at Pelican, Inc., Independent Director at Antibe Therapeutics, Inc. from 2013 to 2015, Director at Profound Medical Corp., Lead Independent Director at POINT Biopharma Global, Inc. from 2021 to 2023, Principal at Procter & Gamble Co., Consultant at Bain & Co., Inc., and Vice President-Business Development at Pharmascience, Inc. Education includes undergraduate and graduate degrees from McGill University, an MBA conferred in 1994 from McGill University, and an undergraduate degree from the London School of Economics & Political Science.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/06/2026 | 1 078 424 ( 1,1 % ) | 6 M $ | 31/05/2026 |
Postes actifs de Jonathan Goodman
| Sociétés | Poste | Début |
|---|---|---|
| KNIGHT THERAPEUTICS INC. | Fondateur | 01/11/2013 |
Massachusetts Bar Association
 Massachusetts Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as lawyers association | Corporate Officer/Principal | - |
Maverix Private Equity
 Maverix Private Equity Investment ManagersFinance Maverix Private Equity invests in companies located in Canada and the United States with a revenue of USD 10 - 100 million. The firm targets companies with operations in the fields of healthcare & wellness, financial services, transportation & logistics, and retail sectors. It provides financing for growth stage capital requirements with an investment size of USD 20 - 100 million. The firm acquires minority interests. | Consultant / Advisor | - |
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Develops next-generation radioligand therapies for the treatment of cancer | Directeur/Membre du Conseil | 01/12/2020 |
POINT Biopharma Corp.
 POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Engages in development and commercialization of radio ligand therapies for the treatment of cancer | Directeur/Membre du Conseil | - |
Medison Biotech 1995 Ltd. | Directeur/Membre du Conseil | - |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Corporate Officer/Principal | - |
Anciens postes connus de Jonathan Goodman
| Sociétés | Poste | Fin |
|---|---|---|
| POIT BIOP | Directeur/Membre du Conseil | 27/12/2023 |
| ANTIBE THERAPEUTICS INC. | Directeur/Membre du Conseil | 27/02/2015 |
| ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░ ░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Jonathan Goodman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
Procter & Gamble Co.
 Procter & Gamble Co. Household/Personal CareConsumer Non-Durables Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | Consumer Non-Durables |
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceuticals | Health Technology |
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Isotechnika, Inc.
 Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops immunosuppressive therapeutic drugs | Health Technology |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Knight Therapeutics, Inc.
 Knight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acquires, sells and markets prescription and over-the-counter pharmaceutical products | Health Technology |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategy, marketing, organization, operations, IT and M&A consulting services | Commercial Services |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases | Health Technology |
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Commercial Services |
Massachusetts Bar Association
Massachusetts Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as lawyers association | Commercial Services |
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Commercial Services |
Pharmascience, Inc.
 Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic and drug products | Health Technology |
Medimetriks Pharmaceuticals, Inc.
 Medimetriks Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, acquires and markets prescription skin care brands | Health Technology |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Antibe Therapeutics, Inc.
 Antibe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops pain and inflammation drugs | Health Technology |
Profound Medical Corp.
 Profound Medical Corp. Medical SpecialtiesHealth Technology Develops and markets medical devices focused on prostate cancer | Health Technology |
Medison Biotech 1995 Ltd. | |
POINT Biopharma Corp.
POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Engages in development and commercialization of radio ligand therapies for the treatment of cancer | Commercial Services |
Maverix Private Equity
Maverix Private Equity Investment ManagersFinance Maverix Private Equity invests in companies located in Canada and the United States with a revenue of USD 10 - 100 million. The firm targets companies with operations in the fields of healthcare & wellness, financial services, transportation & logistics, and retail sectors. It provides financing for growth stage capital requirements with an investment size of USD 20 - 100 million. The firm acquires minority interests. | Finance |
POINT Biopharma Global, Inc.
 POINT Biopharma Global, Inc. BiotechnologyHealth Technology Develops radioligand therapies for the treatment of cancer | Health Technology |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Develops next-generation radioligand therapies for the treatment of cancer | Commercial Services |
The RIde To Conquer Cancer | Commercial Services |
Choisissez Zonebourse 
